We can live in hope, but that's all we can do because Cellmid will certainly not be updating us. Lets have a look at the highlighted "partnerships"
Quest
2012 - Update on license, we were getting these yearly until...
2014 - License update - The last paragraph from the ann below, what since????
Quest (Celera) has until 31 October 2014 to commercialise their lung cancer blood
test with MK included, after which they maintain their ability to use MK, but will lose
exclusivity under the terms of the license agreement.
Zoetis
2014 - Told this was a 4 year animal study ending in November 2018? So what are the results????
Fujikara
2013 - Milestone payment to license midkine....and since then????
Is someone asleep at the wheel???? Hello, McFly, is there anybody home????
- Forums
- ASX - By Stock
- AN1
- present valuation achievable?
present valuation achievable?, page-32
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online